nodes	percent_of_prediction	percent_of_DWPC	metapath
Roxithromycin—CYP1A2—Carmustine—lymphatic system cancer	0.279	0.334	CbGbCtD
Roxithromycin—ABCB1—Mitoxantrone—lymphatic system cancer	0.115	0.137	CbGbCtD
Roxithromycin—CYP3A4—Cytarabine—lymphatic system cancer	0.0999	0.12	CbGbCtD
Roxithromycin—CYP3A4—Teniposide—lymphatic system cancer	0.0984	0.118	CbGbCtD
Roxithromycin—ABCB1—Vincristine—lymphatic system cancer	0.079	0.0946	CbGbCtD
Roxithromycin—CYP3A4—Mitoxantrone—lymphatic system cancer	0.0688	0.0824	CbGbCtD
Roxithromycin—ABCB1—Methotrexate—lymphatic system cancer	0.0479	0.0573	CbGbCtD
Roxithromycin—CYP3A4—Vincristine—lymphatic system cancer	0.0474	0.0567	CbGbCtD
Roxithromycin—Epigastric pain—Mitoxantrone—lymphatic system cancer	0.00552	0.0336	CcSEcCtD
Roxithromycin—Hearing impaired—Fludarabine—lymphatic system cancer	0.00471	0.0287	CcSEcCtD
Roxithromycin—Jaundice—Mechlorethamine—lymphatic system cancer	0.00378	0.023	CcSEcCtD
Roxithromycin—Deafness—Fludarabine—lymphatic system cancer	0.00364	0.0221	CcSEcCtD
Roxithromycin—Erythema multiforme—Mechlorethamine—lymphatic system cancer	0.00329	0.02	CcSEcCtD
Roxithromycin—Tinnitus—Mechlorethamine—lymphatic system cancer	0.00324	0.0197	CcSEcCtD
Roxithromycin—Bronchospasm—Teniposide—lymphatic system cancer	0.00315	0.0192	CcSEcCtD
Roxithromycin—Candida infection—Carmustine—lymphatic system cancer	0.00274	0.0167	CcSEcCtD
Roxithromycin—Vertigo—Mechlorethamine—lymphatic system cancer	0.00272	0.0165	CcSEcCtD
Roxithromycin—Stevens-Johnson syndrome—Fludarabine—lymphatic system cancer	0.00249	0.0151	CcSEcCtD
Roxithromycin—Anaphylactic shock—Mechlorethamine—lymphatic system cancer	0.00247	0.015	CcSEcCtD
Roxithromycin—Anorexia—Mechlorethamine—lymphatic system cancer	0.00236	0.0143	CcSEcCtD
Roxithromycin—Deafness—Vincristine—lymphatic system cancer	0.00222	0.0135	CcSEcCtD
Roxithromycin—Decreased appetite—Mechlorethamine—lymphatic system cancer	0.00215	0.0131	CcSEcCtD
Roxithromycin—Erythema multiforme—Fludarabine—lymphatic system cancer	0.00213	0.013	CcSEcCtD
Roxithromycin—Bronchospasm—Bleomycin—lymphatic system cancer	0.00203	0.0124	CcSEcCtD
Roxithromycin—Hypersensitivity—Mechlorethamine—lymphatic system cancer	0.00182	0.0111	CcSEcCtD
Roxithromycin—Ill-defined disorder—Fludarabine—lymphatic system cancer	0.00182	0.0111	CcSEcCtD
Roxithromycin—Abdominal pain upper—Mitoxantrone—lymphatic system cancer	0.00177	0.0108	CcSEcCtD
Roxithromycin—Malaise—Fludarabine—lymphatic system cancer	0.00177	0.0108	CcSEcCtD
Roxithromycin—Pruritus—Mechlorethamine—lymphatic system cancer	0.00175	0.0106	CcSEcCtD
Roxithromycin—Anorexia—Teniposide—lymphatic system cancer	0.00174	0.0106	CcSEcCtD
Roxithromycin—Diarrhoea—Mechlorethamine—lymphatic system cancer	0.00169	0.0103	CcSEcCtD
Roxithromycin—Discomfort—Fludarabine—lymphatic system cancer	0.00165	0.01	CcSEcCtD
Roxithromycin—Anaphylactic shock—Fludarabine—lymphatic system cancer	0.0016	0.00974	CcSEcCtD
Roxithromycin—Decreased appetite—Teniposide—lymphatic system cancer	0.00158	0.00963	CcSEcCtD
Roxithromycin—Vomiting—Mechlorethamine—lymphatic system cancer	0.00157	0.00956	CcSEcCtD
Roxithromycin—Rash—Mechlorethamine—lymphatic system cancer	0.00156	0.00948	CcSEcCtD
Roxithromycin—Dermatitis—Mechlorethamine—lymphatic system cancer	0.00156	0.00947	CcSEcCtD
Roxithromycin—Anorexia—Fludarabine—lymphatic system cancer	0.00153	0.00928	CcSEcCtD
Roxithromycin—Feeling abnormal—Teniposide—lymphatic system cancer	0.0015	0.00913	CcSEcCtD
Roxithromycin—Nausea—Mechlorethamine—lymphatic system cancer	0.00147	0.00893	CcSEcCtD
Roxithromycin—Jaundice—Mitoxantrone—lymphatic system cancer	0.00146	0.00886	CcSEcCtD
Roxithromycin—Urticaria—Teniposide—lymphatic system cancer	0.00145	0.0088	CcSEcCtD
Roxithromycin—Paraesthesia—Fludarabine—lymphatic system cancer	0.00144	0.00874	CcSEcCtD
Roxithromycin—Hallucination—Carmustine—lymphatic system cancer	0.00143	0.00873	CcSEcCtD
Roxithromycin—Dyspepsia—Fludarabine—lymphatic system cancer	0.00141	0.00857	CcSEcCtD
Roxithromycin—Decreased appetite—Fludarabine—lymphatic system cancer	0.00139	0.00847	CcSEcCtD
Roxithromycin—Hallucination—Vincristine—lymphatic system cancer	0.00137	0.00833	CcSEcCtD
Roxithromycin—Hypersensitivity—Teniposide—lymphatic system cancer	0.00134	0.00816	CcSEcCtD
Roxithromycin—Ill-defined disorder—Bleomycin—lymphatic system cancer	0.00133	0.00812	CcSEcCtD
Roxithromycin—Feeling abnormal—Fludarabine—lymphatic system cancer	0.00132	0.00802	CcSEcCtD
Roxithromycin—Malaise—Bleomycin—lymphatic system cancer	0.0013	0.00789	CcSEcCtD
Roxithromycin—Pruritus—Teniposide—lymphatic system cancer	0.00129	0.00784	CcSEcCtD
Roxithromycin—Diarrhoea—Teniposide—lymphatic system cancer	0.00125	0.00758	CcSEcCtD
Roxithromycin—Discomfort—Bleomycin—lymphatic system cancer	0.00121	0.00736	CcSEcCtD
Roxithromycin—Hypersensitivity—Fludarabine—lymphatic system cancer	0.00118	0.00717	CcSEcCtD
Roxithromycin—Anaphylactic shock—Bleomycin—lymphatic system cancer	0.00117	0.00714	CcSEcCtD
Roxithromycin—Vomiting—Teniposide—lymphatic system cancer	0.00116	0.00704	CcSEcCtD
Roxithromycin—Rash—Teniposide—lymphatic system cancer	0.00115	0.00699	CcSEcCtD
Roxithromycin—Dermatitis—Teniposide—lymphatic system cancer	0.00115	0.00698	CcSEcCtD
Roxithromycin—Headache—Teniposide—lymphatic system cancer	0.00114	0.00694	CcSEcCtD
Roxithromycin—Pruritus—Fludarabine—lymphatic system cancer	0.00113	0.00689	CcSEcCtD
Roxithromycin—Anorexia—Bleomycin—lymphatic system cancer	0.00112	0.00681	CcSEcCtD
Roxithromycin—Diarrhoea—Fludarabine—lymphatic system cancer	0.0011	0.00666	CcSEcCtD
Roxithromycin—Ill-defined disorder—Mitoxantrone—lymphatic system cancer	0.00108	0.00659	CcSEcCtD
Roxithromycin—Nausea—Teniposide—lymphatic system cancer	0.00108	0.00658	CcSEcCtD
Roxithromycin—Vertigo—Vincristine—lymphatic system cancer	0.00108	0.00655	CcSEcCtD
Roxithromycin—Paraesthesia—Bleomycin—lymphatic system cancer	0.00105	0.00641	CcSEcCtD
Roxithromycin—Malaise—Mitoxantrone—lymphatic system cancer	0.00105	0.0064	CcSEcCtD
Roxithromycin—Dermatitis exfoliative—Methotrexate—lymphatic system cancer	0.00102	0.00622	CcSEcCtD
Roxithromycin—Decreased appetite—Bleomycin—lymphatic system cancer	0.00102	0.00621	CcSEcCtD
Roxithromycin—Vomiting—Fludarabine—lymphatic system cancer	0.00102	0.00619	CcSEcCtD
Roxithromycin—Rash—Fludarabine—lymphatic system cancer	0.00101	0.00614	CcSEcCtD
Roxithromycin—Dermatitis—Fludarabine—lymphatic system cancer	0.00101	0.00613	CcSEcCtD
Roxithromycin—Headache—Fludarabine—lymphatic system cancer	0.001	0.0061	CcSEcCtD
Roxithromycin—Discomfort—Mitoxantrone—lymphatic system cancer	0.000982	0.00597	CcSEcCtD
Roxithromycin—Anaphylactic shock—Vincristine—lymphatic system cancer	0.000978	0.00595	CcSEcCtD
Roxithromycin—Anorexia—Carmustine—lymphatic system cancer	0.000977	0.00594	CcSEcCtD
Roxithromycin—Feeling abnormal—Bleomycin—lymphatic system cancer	0.000967	0.00588	CcSEcCtD
Roxithromycin—Anaphylactic shock—Mitoxantrone—lymphatic system cancer	0.000953	0.00579	CcSEcCtD
Roxithromycin—Nausea—Fludarabine—lymphatic system cancer	0.000951	0.00578	CcSEcCtD
Roxithromycin—Urticaria—Bleomycin—lymphatic system cancer	0.000932	0.00567	CcSEcCtD
Roxithromycin—Anorexia—Vincristine—lymphatic system cancer	0.000932	0.00567	CcSEcCtD
Roxithromycin—Paraesthesia—Carmustine—lymphatic system cancer	0.00092	0.0056	CcSEcCtD
Roxithromycin—Anorexia—Mitoxantrone—lymphatic system cancer	0.000908	0.00552	CcSEcCtD
Roxithromycin—Decreased appetite—Carmustine—lymphatic system cancer	0.000891	0.00542	CcSEcCtD
Roxithromycin—Paraesthesia—Vincristine—lymphatic system cancer	0.000878	0.00534	CcSEcCtD
Roxithromycin—Hypersensitivity—Bleomycin—lymphatic system cancer	0.000865	0.00526	CcSEcCtD
Roxithromycin—Paraesthesia—Mitoxantrone—lymphatic system cancer	0.000855	0.0052	CcSEcCtD
Roxithromycin—Decreased appetite—Vincristine—lymphatic system cancer	0.00085	0.00517	CcSEcCtD
Roxithromycin—Feeling abnormal—Carmustine—lymphatic system cancer	0.000844	0.00514	CcSEcCtD
Roxithromycin—Dyspepsia—Mitoxantrone—lymphatic system cancer	0.000838	0.0051	CcSEcCtD
Roxithromycin—Asthma—Methotrexate—lymphatic system cancer	0.000835	0.00508	CcSEcCtD
Roxithromycin—Pruritus—Bleomycin—lymphatic system cancer	0.00083	0.00505	CcSEcCtD
Roxithromycin—Decreased appetite—Mitoxantrone—lymphatic system cancer	0.000828	0.00504	CcSEcCtD
Roxithromycin—Eosinophilia—Methotrexate—lymphatic system cancer	0.000826	0.00503	CcSEcCtD
Roxithromycin—Pancreatitis—Methotrexate—lymphatic system cancer	0.000818	0.00498	CcSEcCtD
Roxithromycin—Feeling abnormal—Mitoxantrone—lymphatic system cancer	0.000785	0.00477	CcSEcCtD
Roxithromycin—Urticaria—Mitoxantrone—lymphatic system cancer	0.000757	0.0046	CcSEcCtD
Roxithromycin—Hypersensitivity—Carmustine—lymphatic system cancer	0.000755	0.00459	CcSEcCtD
Roxithromycin—Vomiting—Bleomycin—lymphatic system cancer	0.000746	0.00454	CcSEcCtD
Roxithromycin—Rash—Bleomycin—lymphatic system cancer	0.00074	0.0045	CcSEcCtD
Roxithromycin—Dermatitis—Bleomycin—lymphatic system cancer	0.000739	0.0045	CcSEcCtD
Roxithromycin—Stevens-Johnson syndrome—Methotrexate—lymphatic system cancer	0.000738	0.00449	CcSEcCtD
Roxithromycin—Hypersensitivity—Vincristine—lymphatic system cancer	0.000721	0.00438	CcSEcCtD
Roxithromycin—Hypersensitivity—Mitoxantrone—lymphatic system cancer	0.000702	0.00427	CcSEcCtD
Roxithromycin—Diarrhoea—Carmustine—lymphatic system cancer	0.000701	0.00426	CcSEcCtD
Roxithromycin—Nausea—Bleomycin—lymphatic system cancer	0.000697	0.00424	CcSEcCtD
Roxithromycin—Dizziness—Carmustine—lymphatic system cancer	0.000678	0.00412	CcSEcCtD
Roxithromycin—Diarrhoea—Vincristine—lymphatic system cancer	0.000669	0.00407	CcSEcCtD
Roxithromycin—Diarrhoea—Mitoxantrone—lymphatic system cancer	0.000652	0.00396	CcSEcCtD
Roxithromycin—Vomiting—Carmustine—lymphatic system cancer	0.000651	0.00396	CcSEcCtD
Roxithromycin—Dizziness—Vincristine—lymphatic system cancer	0.000647	0.00393	CcSEcCtD
Roxithromycin—Rash—Carmustine—lymphatic system cancer	0.000646	0.00393	CcSEcCtD
Roxithromycin—Dermatitis—Carmustine—lymphatic system cancer	0.000645	0.00393	CcSEcCtD
Roxithromycin—Headache—Carmustine—lymphatic system cancer	0.000642	0.0039	CcSEcCtD
Roxithromycin—Erythema multiforme—Methotrexate—lymphatic system cancer	0.000632	0.00384	CcSEcCtD
Roxithromycin—Tinnitus—Methotrexate—lymphatic system cancer	0.000623	0.00379	CcSEcCtD
Roxithromycin—Vomiting—Vincristine—lymphatic system cancer	0.000622	0.00378	CcSEcCtD
Roxithromycin—Rash—Vincristine—lymphatic system cancer	0.000617	0.00375	CcSEcCtD
Roxithromycin—Dermatitis—Vincristine—lymphatic system cancer	0.000616	0.00375	CcSEcCtD
Roxithromycin—Headache—Vincristine—lymphatic system cancer	0.000613	0.00373	CcSEcCtD
Roxithromycin—Nausea—Carmustine—lymphatic system cancer	0.000609	0.0037	CcSEcCtD
Roxithromycin—Vomiting—Mitoxantrone—lymphatic system cancer	0.000606	0.00368	CcSEcCtD
Roxithromycin—Rash—Mitoxantrone—lymphatic system cancer	0.000601	0.00365	CcSEcCtD
Roxithromycin—Dermatitis—Mitoxantrone—lymphatic system cancer	0.0006	0.00365	CcSEcCtD
Roxithromycin—Headache—Mitoxantrone—lymphatic system cancer	0.000597	0.00363	CcSEcCtD
Roxithromycin—Nausea—Vincristine—lymphatic system cancer	0.000581	0.00353	CcSEcCtD
Roxithromycin—Nausea—Mitoxantrone—lymphatic system cancer	0.000566	0.00344	CcSEcCtD
Roxithromycin—Ill-defined disorder—Methotrexate—lymphatic system cancer	0.00054	0.00328	CcSEcCtD
Roxithromycin—Malaise—Methotrexate—lymphatic system cancer	0.000524	0.00319	CcSEcCtD
Roxithromycin—Vertigo—Methotrexate—lymphatic system cancer	0.000522	0.00318	CcSEcCtD
Roxithromycin—Discomfort—Methotrexate—lymphatic system cancer	0.000489	0.00298	CcSEcCtD
Roxithromycin—Anaphylactic shock—Methotrexate—lymphatic system cancer	0.000475	0.00289	CcSEcCtD
Roxithromycin—Anorexia—Methotrexate—lymphatic system cancer	0.000452	0.00275	CcSEcCtD
Roxithromycin—Paraesthesia—Methotrexate—lymphatic system cancer	0.000426	0.00259	CcSEcCtD
Roxithromycin—Dyspepsia—Methotrexate—lymphatic system cancer	0.000418	0.00254	CcSEcCtD
Roxithromycin—Decreased appetite—Methotrexate—lymphatic system cancer	0.000413	0.00251	CcSEcCtD
Roxithromycin—Feeling abnormal—Methotrexate—lymphatic system cancer	0.000391	0.00238	CcSEcCtD
Roxithromycin—Urticaria—Methotrexate—lymphatic system cancer	0.000377	0.00229	CcSEcCtD
Roxithromycin—Hypersensitivity—Methotrexate—lymphatic system cancer	0.00035	0.00213	CcSEcCtD
Roxithromycin—Pruritus—Methotrexate—lymphatic system cancer	0.000336	0.00204	CcSEcCtD
Roxithromycin—Diarrhoea—Methotrexate—lymphatic system cancer	0.000325	0.00198	CcSEcCtD
Roxithromycin—Dizziness—Methotrexate—lymphatic system cancer	0.000314	0.00191	CcSEcCtD
Roxithromycin—Vomiting—Methotrexate—lymphatic system cancer	0.000302	0.00184	CcSEcCtD
Roxithromycin—Rash—Methotrexate—lymphatic system cancer	0.000299	0.00182	CcSEcCtD
Roxithromycin—Dermatitis—Methotrexate—lymphatic system cancer	0.000299	0.00182	CcSEcCtD
Roxithromycin—Headache—Methotrexate—lymphatic system cancer	0.000297	0.00181	CcSEcCtD
Roxithromycin—Nausea—Methotrexate—lymphatic system cancer	0.000282	0.00171	CcSEcCtD
